Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1986 1
1989 1
1992 1
1994 1
1995 1
1996 1
1998 1
1999 1
2000 1
2001 1
2003 2
2004 3
2005 6
2006 10
2007 8
2008 11
2009 9
2010 17
2011 10
2012 8
2013 16
2014 20
2015 11
2016 14
2017 13
2018 10
2019 19
2020 12
2021 20
2022 27
2023 21
2024 26
2025 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Results by year

Filters applied: . Clear all
Page 1
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes.
Arslanian SA, Hannon T, Zeitler P, Chao LC, Boucher-Berry C, Barrientos-Pérez M, Bismuth E, Dib S, Cho JI, Cox D; AWARD-PEDS Investigators. Arslanian SA, et al. N Engl J Med. 2022 Aug 4;387(5):433-443. doi: 10.1056/NEJMoa2204601. Epub 2022 Jun 4. N Engl J Med. 2022. PMID: 35658022 Clinical Trial.
Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: A randomized placebo-controlled double-blind clinical trial.
Moussavi Z, Uehara M, Rutherford G, Lithgow B, Millikin C, Wang X, Saha C, Mansouri B, Omelan C, Fellows L, Fitzgerald PB, Koski L. Moussavi Z, et al. Among authors: saha c. Neurotherapeutics. 2024 Apr;21(3):e00331. doi: 10.1016/j.neurot.2024.e00331. Epub 2024 Feb 14. Neurotherapeutics. 2024. PMID: 38360452 Free PMC article. Clinical Trial.
Neuroendocrine regulation in stroke.
Datta A, Saha C, Godse P, Sharma M, Sarmah D, Bhattacharya P. Datta A, et al. Among authors: saha c. Trends Endocrinol Metab. 2023 May;34(5):260-277. doi: 10.1016/j.tem.2023.02.005. Epub 2023 Mar 13. Trends Endocrinol Metab. 2023. PMID: 36922255 Review.
Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys).
Okikiolu J, Woodley C, Cadman-Davies L, O'Sullivan J, Radia D, Garcia NC, Harrington P, Kordasti S, Asirvatham S, Sriskandarajah P, Saunders J, Saha C, Sanchez I, deLavallade H, McLornan DP, Harrison CN. Okikiolu J, et al. Among authors: saha c. Leuk Res Rep. 2022 Dec 16;19:100360. doi: 10.1016/j.lrr.2022.100360. eCollection 2023. Leuk Res Rep. 2022. PMID: 36590864 Free PMC article.
Key considerations for a prostate cancer mRNA vaccine.
Lin G, Elkashif A, Saha C, Coulter JA, Dunne NJ, McCarthy HO. Lin G, et al. Among authors: saha c. Crit Rev Oncol Hematol. 2025 Apr;208:104643. doi: 10.1016/j.critrevonc.2025.104643. Epub 2025 Feb 1. Crit Rev Oncol Hematol. 2025. PMID: 39900315 Free article. Review.
Nucleic acid vaccination strategies for ovarian cancer.
Saha C, Bojdo J, Dunne NJ, Duary RK, Buckley N, McCarthy HO. Saha C, et al. Front Bioeng Biotechnol. 2022 Nov 7;10:953887. doi: 10.3389/fbioe.2022.953887. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36420446 Free PMC article. Review.
Current microfluidic platforms for reverse engineering of cornea.
Li Q, Wong HL, Ip YL, Chu WY, Li MS, Saha C, Shih KC, Chan YK. Li Q, et al. Among authors: saha c. Mater Today Bio. 2023 Apr 11;20:100634. doi: 10.1016/j.mtbio.2023.100634. eCollection 2023 Jun. Mater Today Bio. 2023. PMID: 37139464 Free PMC article. Review.
286 results